HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High resolution crystal structure of human β-glucuronidase reveals structural basis of lysosome targeting.

Abstract
Human β-glucuronidase (GUS) cleaves β-D-glucuronic acid residues from the non-reducing termini of glycosaminoglycan and its deficiency leads to mucopolysaccharidosis type VII (MPSVII). Here we report a high resolution crystal structure of human GUS at 1.7 Å resolution and present an extensive analysis of the structural features, unifying recent findings in the field of lysosome targeting and glycosyl hydrolases. The structure revealed several new details including a new glycan chain at Asn272, in addition to that previously observed at Asn173, and coordination of the glycan chain at Asn173 with Lys197 of the lysosomal targeting motif which is essential for phosphotransferase recognition. Analysis of the high resolution structure not only provided new insights into the structural basis for lysosomal targeting but showed significant differences between human GUS, which is medically important in its own right, and E. coli GUS, which can be selectively inhibited in the human gut to prevent prodrug activation and is also widely used as a reporter gene by plant biologists. Despite these differences, both human and E. coli GUS share a high structure homology in all three domains with most of the glycosyl hydrolases, suggesting that they all evolved from a common ancestral gene.
AuthorsMd Imtaiyaz Hassan, Abdul Waheed, Jeffery H Grubb, Herbert E Klei, Sergey Korolev, William S Sly
JournalPloS one (PLoS One) Vol. 8 Issue 11 Pg. e79687 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID24260279 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glycosaminoglycans
  • Glucuronidase
Topics
  • Amino Acid Sequence
  • Crystallography, X-Ray
  • Glucuronidase (chemistry, metabolism)
  • Glycosaminoglycans (metabolism)
  • Humans
  • Lysosomes (metabolism)
  • Molecular Sequence Data

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: